Mohamed osman Mohamed Elhasan <br/><br/>
Role of 3   , 4    & 5    line chemotherapy in metastatic breast cancer :   Treatment outcome and toxicity in nemrock between 2005 and 2010 /  
 دور خط العلاج الكيماوى الثالث والرابع والخامس فى علاج حالات سرطان الثدى المنتشر :   نتائج العلاج والاعراض الجانبية بمركز قصر العينى لعلاج الأورام والطب النووى فى الفترة من 2005 - 2010 : دراسة تحليلية إرتجاعية 
Mohamed osman Mohamed Elhasan ; Supervised Mohamed Ali Morsi Abdien , Mona Ahmed Aboulenein , Wesam Elsharief 
 - Cairo :   Mohamed osman Mohamed Elhasan ,   2012 
 - 84Leaves :   charts ;   30cm 
<br/><br/>Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Oncology ( Clinical ) 
<br/><br/> The aim of this study was to determine the benefit of chemotherapy beyond the second line in patients with metastatic breast cancer ; then , if a benefit was established , to identify patients who better benefit from the treatment . A total of 420 female patients with metastatic breast cancer were diagnosed in NEMROCK between 2005 and 2010 of whom orignally 52 female patients , later reduced to 24 female patients , and further reduced to 9 female patients received a third , fourth and fifth lines of chemotherapy , respectively 
<br/><br/>
<br/><br/><label>Subjects--Index Terms: </label>Chemotherapy 3   , 4    & 5   line Metastatic breast cancer  Treatment outcome and toxicity in nemrock